Growth Hormone Resistance of Beta-cells in People With a Family History of Type 2 Diabetes

Part of paid clinical trials in Columbia, Missouri.

Sponsor
University of Missouri-Columbia
Study ID
NCT06571500
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 59 Years
Healthy Volunteers
Accepted

Study Details

The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with a family history of type 2 diabetes at the University of Missouri. Our aim is to advance understanding of how growth hormone affects beta-cells and risk factors for developing type 2 diabetes.

Key Dates

Start date
Jul 15, 2025
Status verified
Apr 2026
Primary completion
Sep 1, 2028
Completion
Sep 1, 2030

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Men and women with a family history of type 2 diabetes
  • Arm: Men and women without a family history of type 2 diabetes

Primary Outcome Measure

Beta-cell function [ Time Frame: before and 7 days after rhGH administration ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Missouri School of MedicineColumbiaMissouri65212
Bettina Mittendorfer
[email protected]
573-882-9377

Find similar trials in Columbia, MO

By condition
Obesity / overweight
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
University of Missouri School of Medicine· Columbia, MO

Related Studies